Download Free Sample
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of anima.....
Europe Poultry Drugs Market By Drug Type By Animal Type, and Geography
Europe Poultry Drugs Market By Drug Type By Animal Type, and Geography
Europe Poultry Drugs Market size was valued at US$ XX Mn in 2023 and poised to grow at significant CAGR of x% over 2024-2030. Drugs are the chemical substances used to diagnose, treat, prevent, or cure the various diseases. Poultry drugs are used to prevent or cure the various poultry diseases such as infectious diseases, gout, helminthiasis, and nutritional disorders among others. Rise in the demand for healthy meat and eggs, increase in the R&D activities for the innovation of newer drugs, collaborations and acquisitions between the companies, increase in prevalence of various infectious diseases and high awareness about the poultry diseases and drugs among veterinary professionals are expected to boost the Europe poultry drugs market. However, stringent regulatory policies for product approval, ban of antibiotics usage in poultry, high cost of R&D activities, and adverse effects associated with the drugs may restrain the growth of Europe poultry drugs market over the forecast timeframe.
A lack of animal health awareness in some areas may have a detrimental impact on market growth. The poultry sector's high cost of production, rising feed costs, and trade tensions may hinder the market's growth throughout the projection period. Furthermore, farmers' lack of information about novel therapies for poultry illnesses is projected to stymie future market growth.
Geographically, Europe poultry drugs market is segmented into Germany, France, U.K, Italy Spain, Russia, Poland, and Rest of Europe. Germany poultry drugs market growth attributed to rise in demand for healthy meat, increase in the R&D activities for the innovation of newer drugs, rise in prevalence infectious diseases, and rise in per capita income. France poultry drugs market has a lucrative growth due to disease outbreak in poultry, innovation of newer drugs and vaccines by the companies, and adoption of newer drugs in the market. U.K. poultry drugs market is growing due to government support for the poultry production, increase in animal healthcare expenditure, and rise in funding from the government organiations for the development of newer drugs.
Latin America
Europe
Asia Pacific
Middle East
North America
|
Report Benchmarks |
Details |
|
By Drug Type |
|
|
By Animal Type |
|
|
By Country, |
|
Download Free Sample Report
The Europe Poultry Drugs Market Market size was at valued US$ XX Mn in 2023 and poised to grow at significant CAGR of x% over 2024-2030.
The Europe Poultry Drugs Market data: Europe (Germany, France, Italy, Spain, and United Kingdom (UK),
The Europe Poultry Drugs Market key players are Zoetis (Pfizer, Inc.) (U.S.), Merck & Co. Inc. (U.S), Virbac S.A. (France), Boehringer Ingelheim Vetmedica (Germany), Elanco (U.S.), Bayer Animal Health (Germany), Phibro Animal health Corporation (U.S.), Zydus AHL (India), Ceva Sante Animale (France)
| 1.Executive Summary |
| 2. Europe Poultry Drugs Market Introduction |
| 2.1. Europe Poultry Drugs Market - Taxonomy |
| 2.2. Europe Poultry Drugs Market - Definitions |
| 2.2.1.Drug Type |
| 2.2.2.Animal Type |
| 2.2.3.Country |
| 3. Europe Poultry Drugs Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4. Europe Poultry Drugs Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5. Europe Poultry Drugs Market By Drug Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Parasiticides |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Antibiotics |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 5.3. Anti-inflammatory Drugs |
| 5.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.3.3. Market Opportunity Analysis |
| 5.4. Others |
| 5.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.4.3. Market Opportunity Analysis |
| 6. Europe Poultry Drugs Market By Animal Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Turkey |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Chicken |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Goose |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Duck |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 6.5. Others |
| 6.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.5.3. Market Opportunity Analysis |
| 7. Europe Poultry Drugs Market By Country, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Europe |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Germany |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. France |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 7.4. Italy |
| 7.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.4.3. Market Opportunity Analysis |
| 7.5. United Kingdom (UK) |
| 7.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.5.3. Market Opportunity Analysis |
| 7.6. Spain |
| 7.6.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.6.3. Market Opportunity Analysis |
| 8. Competition Landscape |
| 8.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 8.2.1.Zoetis (Pfizer, Inc.) (U.S.) |
| 8.2.2.Merck & Co. Inc. (U.S) |
| 8.2.3.Virbac S.A. (France) |
| 8.2.4.Boehringer Ingelheim Vetmedica (Germany) |
| 8.2.5.Elanco (U.S.) |
| 8.2.6.Bayer Animal Health (Germany) |
| 8.2.7.Phibro Animal health Corporation (U.S.) |
| 8.2.8.Zydus AHL (India) |
| 8.2.9.Ceva Sante Animale (France) |
| 9. Research Methodology |
| 10. Appendix and Abbreviations |
Key Market Players
Author
Manoj Kumar is a postgraduate in Life Sciences with over seven years of dedicated experience in the fields of animal health and agriculture. His passion lies in unraveling the complexities of these domains through rigorous research and practical insights. Manoj Kumar’s journey has been marked by several key achievements: as a market analyst and competitive intelligence expert, he dissects data to provide actionable insights for global clients. Simultaneously, he champions animal healthcare, diagnosing ailments, and designing preventive care strategies. In the realm of agriculture, his focus on sustainable practices, emphasizing crop nutrition, soil health, and precision agriculture. His holistic approach and commitment to advancing science make him a respected figure in the ever-evolving landscape of life sciences.